Literature DB >> 27567329

A randomized trial of quilizumab in adults with refractory chronic spontaneous urticaria.

Jeffrey M Harris1, Christopher R Cabanski2, Heleen Scheerens2, Divya Samineni2, Mary S Bradley2, Colette Cochran2, Petra Staubach3, Martin Metz4, Gordon Sussman5, Marcus Maurer4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27567329     DOI： 10.1016/j.jaci.2016.06.023

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  11 in total

1.  A Comprehensive Approach to Urticaria: From Clinical Presentation to Modern Biological Treatments Through Pathogenesis.

Authors:  Marco Folci; Giacomo Ramponi; Enrico Brunetta
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Urticaria and Angioedema: an Update on Classification and Pathogenesis.

Authors:  Susanne Radonjic-Hoesli; Kathrin Scherer Hofmeier; Sara Micaletto; Peter Schmid-Grendelmeier; Andreas Bircher; Dagmar Simon
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 3.  Past, present, and future of anti-IgE biologics.

Authors:  Pascal Guntern; Alexander Eggel
Journal:  Allergy       Date:  2020-04-21       Impact factor: 13.146

Review 4.  Targeted Therapy for Chronıc Spontaneous Urtıcarıa: Ratıonale and Recent Progress.

Authors:  Ana M Giménez-Arnau; Andaç Salman
Journal:  Drugs       Date:  2020-11       Impact factor: 9.546

Review 5.  IgE-Related Chronic Diseases and Anti-IgE-Based Treatments.

Authors:  Arnau Navinés-Ferrer; Eva Serrano-Candelas; Gustavo-J Molina-Molina; Margarita Martín
Journal:  J Immunol Res       Date:  2016-12-21       Impact factor: 4.818

Review 6.  Looking forward to new targeted treatments for chronic spontaneous urticaria.

Authors:  Emek Kocatürk; Marcus Maurer; Martin Metz; Clive Grattan
Journal:  Clin Transl Allergy       Date:  2017-01-10       Impact factor: 5.871

7.  Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells.

Authors:  Eva Serrano-Candelas; Rubén Martínez-Aranguren; Olga Vega; Gabriel Gastaminza; Joan Bartra; Maria Teresa Audicana; Jorge M Núñez-Córdoba; Jaime Algorta; Antonio Valero; Margarita Martin; Marta Ferrer
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

Review 8.  Tracing IgE-Producing Cells in Allergic Patients.

Authors:  Julia Eckl-Dorna; Sergio Villazala-Merino; Nicholas James Campion; Maria Byazrova; Alexander Filatov; Dmitry Kudlay; Antonina Karsonova; Ksenja Riabova; Musa Khaitov; Alexander Karaulov; Verena Niederberger-Leppin; Rudolf Valenta
Journal:  Cells       Date:  2019-08-28       Impact factor: 6.600

Review 9.  Total IgE as a Marker for Chronic Spontaneous Urticaria.

Authors:  Sabine Altrichter; Jie Shen Fok; Qingqing Jiao; Pavel Kolkhir; Polina Pyatilova; Sherezade Moñino Romero; Jörg Scheffel; Frank Siebenhaar; Carolin Steinert; Dorothea Terhorst-Molawi; Yi Kui Xiang; Martin K Church; Marcus Maurer
Journal:  Allergy Asthma Immunol Res       Date:  2021-03       Impact factor: 5.764

Review 10.  Targeting the FcεRI Pathway as a Potential Strategy to Prevent Food-Induced Anaphylaxis.

Authors:  Melanie C Dispenza; Bruce S Bochner; Donald W MacGlashan
Journal:  Front Immunol       Date:  2020-12-17       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.